首页|期刊导航|中德临床肿瘤学杂志（英文版）|Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen

Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen

Dejian Pan Biao Wang Weibing Wang Yuanwen Wu Xijian Zhou Donglin Wang

中德临床肿瘤学杂志（英文版）Issue(7)：299-304,6.

中德临床肿瘤学杂志（英文版）Issue(7)：299-304,6.DOI:10.1007/s10330-014-1337-9

Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen

Dejian Pan ¹Biao Wang ¹Weibing Wang ¹Yuanwen Wu ¹Xijian Zhou ¹Donglin Wang²

作者信息

1. Department of 0ncology, 101st Hospital of PLA, Clinical Medical College of Jiangsu University, Wuxi 214044, China
2. Department of 0ncology, Affiliated Tongji Hospital, Tongji University, Shanghai 200065, China
折叠

摘要

关键词

gefitinib/γ-ray stereotactic body radiation therapy (SBRT)/epidermal growth factor receptor (EGFR) mutations/senile/first-line regimen

Key words

gefitinib/γ-ray stereotactic body radiation therapy (SBRT)/epidermal growth factor receptor (EGFR) mutations/senile/first-line regimen

引用本文复制引用

Dejian Pan,Biao Wang,Weibing Wang,Yuanwen Wu,Xijian Zhou,Donglin Wang..Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen[J].中德临床肿瘤学杂志（英文版）,2014,(7):299-304,6.

基金项目

Supported by a grant from the Clinical Medicine Sciences Foundation of Jiangsu University (No. JLY20080085) （No. JLY20080085）

中德临床肿瘤学杂志（英文版）

OACSTPCD

ISSN：2095-9621

访问量0

下载量0

段落导航